The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'September, 2016'. If you still can't find what you are looking for, try using the search box.
29 September 2016: Hay on Wye, UK – Leading pharmaceutical outsourcing services provider PCI Pharma Services has announced the appointment of Jens Peter Nielsen as Business Development Manager in its European commercial packaging team, which includes its Hay-on-Wye site in Wales, UK, and a recognized center of excellence for packaging, one of four locations in Europe.
Read the rest of entry »
27 September 2016: Cambridge, UK - Sareum Holdings plc (AIM:SAR), the specialist cancer drug discovery and development company, is pleased to announce that its co-investment partner, the CRT Pioneer Fund, has today licensed exclusive and worldwide rights for the Chk1 inhibitor cancer drug candidate CCT245737 (to be renamed PNT737) to ProNAi Therapeutics, Inc. (NASDAQ: DNAI).
26 September 2016, Abingdon, UK: OBN, the leading membership organisation supporting the UK’s innovative life sciences companies, and the West Sussex Health and Life Sciences Cluster (WSHLSC) announced today that they are launching a top-quality funding and export support event in West Sussex aimed at health and life science companies.
<p>26 September 2016: Oxford, UK. Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy ('DMD') and <i>Clostridium difficile</i> infection, today announces it has received Fast Track designation from the US Food and Drug Administration ('FDA') for ezutromid in the treatment of DMD. Ezutromid is a utrophin modulator and represents a potential disease modifying treatment for all patients with the fatal muscle wasting disease DMD.</p>
20 September 2016: Philadelphia, USA – Leading pharmaceutical provider PCI Pharma Services will bring its expertize to the stage at CPHI Worldwide (Barcelona, October 4-6 2016) with two Speakers Corner slots at the ICSE Exhibitor Showcase.
22 September 2016: Gosport, UK - Wickham Laboratories Ltd will exhibit on Stand 305 at Medtec Ireland, October 4-5.
21 September 2016 - Physiomics announces that it has completed a placing, conditional only on Admission, to raise £555,000.00 from the issue of 2,220,000,000 new ordinary shares of 0.004p each ("Ordinary Shares") at a price of 0.025p per share, through Hybridan LLP (the "Placing"). Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealing is expected to commence on 28th September 2016.
20 September 2016: Abingdon, UK - AMSBIO has produced a new 24-page guide that brings together applications, protocols, results and citations to provide an informative resource for researchers using heparan sulfate antibodies.
19th September 2016: London, UK - SynbiCITE, in association with the Industrial Biotechnology Innovation Centre (IBiolC) will run another of its 4-Day MBA courses for biotech entrepreneurs in Glasgow from 20-24 November. This interactive course will cover key strategies required to establish, build and manage a biotechnology company and aid in developing the entrepreneurship of future leaders.
19 September 2016: Gosport, UK - Wickham Laboratories is pleased to introduce stability storage and testing as its latest service offering.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, email@example.com, and we will post.